The Smac Mimetic BV6 Improves NK Cell-Mediated Killing of Rhabdomyosarcoma Cells by Simultaneously Targeting Tumor and Effector Cells

Kyra Fischer(Goethe University Frankfurt), Evelyn Ullrich(Goethe University Frankfurt)
Frontiers in Immunology
March 7, 2017
Cited by 26


Related Papers